#50 HBOT-2 Neurological and Cancer Primary Considerations

$59.00

CE 2.0 Total | 2.0 of which are Pharm

Part-2 of the HBOT series with in dpeth information regarding HBOT and cancer as well as neurological illness

SKU: NAEMCDAMonthlyWebinar#50 Category:

Description

CE 2.0 Total | 2.0 of which are Pharm

Part-2 of the HBOT series with in dpeth information regarding HBOT and cancer as well as neurological illness

There are no reviews yet.

Be the first to review “#50 HBOT-2 Neurological and Cancer Primary Considerations”

Related products